Back

Monocytes from CAD patients displayed M1 phenotype and released inflammatory mediators inducing endothelial dysfunction: M1 resolution and endothelial protection by SGLT2i + GLP-1Ra synergism

29 August 2025 (07:00 - 18:00)
Organised by: Logo
Congress Presentation Part of: Molecular actions of GLP-1 agonists and incretins Drugs, Drug Targets ESC Professional Premium Access ESC Congress 2025 European Society of Cardiology

About the speaker

Photo
Doctor Ali Mroueh

Strasbourg (France)

2 More presentations in this session

Presentation thumbnail
State-of-the-art lecture on molecular actions of GLP-1 agonists and incretins
Professor E. Osto (Graz, AT)
Slides Video
Presentation thumbnail
A dual glucose-dependent insulinotropic polypeptide (GIP) and glucagon-like peptide-1 (GLP-1) receptor agonist increases blood pressure in stroke-prone spontaneous hypertensive rats
Doctor Y. Ono (Fukuoka, JP)
Abstract Slides Video

Access the full session

Session thumbnail
Molecular actions of GLP-1 agonists and incretins
Video

The Event

Event poster

ESC Congress 2025

29 August - 1 September 2025
You may be interested in
thumbnail
Congress Presentation
Beyond blood glucose: the cardiovascular and renal effects of incretin therapies and SGLT2 inhibitors
thumbnail
Congress Presentation
How has the concept of incretin mimetics evolved since SELECT?
thumbnail
Congress Presentation
State-of-the-art lecture on molecular actions of GLP-1 agonists and incretins

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources